Oslo and Akershus University College of Applied Sciences, Faculty of Health Sciences, Oslo, Norway.
Aging Clin Exp Res. 2011 Aug;23(4):296-303. doi: 10.1007/BF03324967.
The aims of this study were to assess correlations between two health-related quality of life (HRQOL) measurements, the Quality of Life Questionnaire issued by the European Foundation for Osteoporosis (QUALEFFO- 41) and the total score of The General Health Questionnaire (GHQ-20) in a population of women living at home with well-established osteoporosis and at least one vertebral fracture, as well as the internal consistency and floor and ceiling effects of these measurements. Also examined were the mean values of these measurements, to ascertain whether they were significantly different for the group consisting of 75% of the women with the best performance on mobility and balance, compared with the other participants.
Across-sectional study of 89 women aged 60 years or more, evaluated by QUALEFFO-41 (consisting of one total score and five section scores), GHQ-20 (one total score), maximum speed and Functional Reach (FR).
Cronbach's alpha coefficient for measurements of HRQOL ranged from 0.61 to 0.92. Significant correlations between 'QUALEFFO- 41: total score' and 'GHQ-20: total score' were 0.49, and between 'GHQ-20: total score' and section scores of 'QUALEFFO-41' 0.28-0.63. Those in the 75% group with the highest maximum walking speed or longest distance on FR reported significantly better disease-specific HRQOL than the others, with poorer results on these tests.
Disease-specific and generic HRQOL instruments are not redundant when applied together, and the disease-specific 'QUALEFFO-41' and generic GHQ-20 measure different aspects of HRQOL.
本研究旨在评估两种健康相关生活质量(HRQOL)测量方法之间的相关性,这两种方法是欧洲骨质疏松基金会(EFOS)发布的生活质量问卷(QUALEFFO-41)和一般健康问卷(GHQ-20)的总分,研究对象为居住在家中、患有明确骨质疏松症且至少有一处椎体骨折的女性人群,并评估这些测量方法的内部一致性和地板效应和天花板效应。还检查了这些测量方法的平均值,以确定对于移动性和平衡能力表现最佳的女性组(占女性总数的 75%)与其他参与者相比,这些测量方法的平均值是否存在显著差异。
对 89 名年龄在 60 岁及以上的女性进行横断面研究,评估内容包括 QUALEFFO-41(包含一个总分和五个部分得分)、GHQ-20(一个总分)、最大速度和功能性伸展(FR)。
HRQOL 测量的克朗巴赫 α 系数范围为 0.61 至 0.92。“QUALEFFO-41:总分”和“GHQ-20:总分”之间存在显著相关性,为 0.49,“GHQ-20:总分”与“QUALEFFO-41”的部分得分之间的相关性为 0.28-0.63。在最大步行速度或 FR 最长距离上处于前 75%组的女性报告称,疾病特异性 HRQOL 明显好于其他女性,而这些测试的结果较差。
当一起使用时,疾病特异性和通用 HRQOL 工具并不多余,疾病特异性“QUALEFFO-41”和通用 GHQ-20 测量 HRQOL 的不同方面。